Latest news
Promatix secures Innovate UK grant to advance cis-bispecific ADC programme - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMTPromatix Biosciences Wins Innovate UK Grant for Cancer ADC Program - Contract PharmaContract Pharma · Thu, 30 Jul 2026 17:46:21 GMTVERAXA Biotech Announces Advancement of VXA-222 Bispecific ADC Program in Collaboration with OmniAb - Quiver QuantitativeQuiver Quantitative · Mon, 27 Jul 2026 11:13:00 GMTVeraxa Biotech (VRXA) moves bispecific ADC VXA-222 program forward - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT